Premium
Natalizumab‐induced acquired perforating dermatosis
Author(s) -
Fisher R. M.,
Hadley G.,
Ieremia E.,
Moswela O.,
Zaki F.,
DeLuca G. C.,
McPherson T.
Publication year - 2021
Publication title -
clinical and experimental dermatology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/ced.14699
Subject(s) - natalizumab , medicine , dermatology , pathology , disease
Click here for the corresponding questions to this CME article.